‘Theranos But Real’: New Blood-Testing Startup Says It Can Predict Health Risks
With all the renewed interest around the saga of Theranos, two startup founders, Omar Abudayyeh and Jonathan Gootenberg, made the tongue-in-cheek decision to plunk down about $12 for the rights to the URL: theranosbutworks.com. That URL redirects to the main website for their 16-month-old health- and blood-testing company, Helios, which is coming out of stealth on Wednesday. With just a drop of blood drawn from a small, needle-free device, Abudayyeh, 36, and Gootenberg, 35, say the company can measure over 1,000 proteins within someone’s body that provide insight into their current state of health and predictions about a person’s risk of diseases like heart failure, blood cancers and Alzheimer’s disease over the next 10 years.
Aggregator site: only the publisher's summary is shown here. Read the full story at the source.
Read full story →